Funded Startups in Marlborough
Recent disclosed rounds in Marlborough span from 2026-01-13 (Lifeward, $27M) down to 2021-09-27 (Rewalk Robotics, $33M), with the newest entry being Solid…
Recent disclosed rounds in Marlborough span from 2026-01-13 (Lifeward, $27M) down to 2021-09-27 (Rewalk Robotics, $33M), with the newest entry being Solid Biosciences on 2026-03-06 at $240M. That $240M round is a clear outlier versus the rest of the disclosed amounts in this slice: the next-largest is LiquidStack at $20M (2024-09-19), while many other rounds cluster between the single-digit millions and $50M-or-below (e.g., Akoya Biosciences at $44M on 2023-06-07, OneShield Software at $50M on 2022-01-27).
Sector and stage signals also concentrate. Biotechnology appears in 7 of the 17 rows (e.g., Solid Biosciences $240M on 2026-03-06; Phio Pharmaceuticals $13M on 2025-11-03; Akoya Biosciences $44M on 2023-06-07), and “Series Unknown” appears in 12 of 17 entries (e.g., Lifeward 2026-01-13 at $27M; Scitara 2023-11-03 at $9M). Most rounds fall in biotech and electronics/health-adjacent categories, and the timeline shows a dense middle stretch from 2022-01-27 through 2024-09-19 before the latest 2025–2026 biotechnology-heavy updates.
Most recent rounds
17 shownRelated listings
Frequently asked
What stands out as the largest disclosed round in Marlborough, and how does it compare to the next-largest?
Solid Biosciences’ 2026-03-06 disclosed round is $240M, which dwarfs the rest of the disclosed amounts in this listing. The next-largest disclosed amount is LiquidStack at $20M on 2024-09-19, with Akoya Biosciences at $44M (2023-06-07) still far below the $240M outlier.
Do the most recent rounds cluster into a narrow time window, or are they spread out?
The 17 rows cover 2021-09-27 through 2026-03-06, but there is a noticeable concentration from 2022-01-27 to 2024-09-19, including OneShield Software ($50M, 2022-01-27), Skyscape ($900K, 2022-02-15), LiquidStack ($20M, 2024-09-19), and DNAiTECH ($460K, 2024-10-21). The newest updates then continue into 2025–2026 with Phio Pharmaceuticals ($13M, 2025-11-03) and Solid Biosciences ($240M, 2026-03-06).
Is biotechnology over-represented among these Marlborough-funded companies?
Yes. Biotechnology accounts for 7 of 17 rows, including Solid Biosciences ($240M, 2026-03-06), Phio Pharmaceuticals ($13M, 2025-11-03), Akoya Biosciences ($44M, 2023-06-07), and AssayQuant Technologies ($5M, 2023-07-10). Other sectors appear less frequently (e.g., Consumer Electronics has 3 rows: LiquidStack, Wyebot, Skyscape).
How dominant is “Series Unknown” in this dataset, and what does that imply for diligence?
“Series Unknown” appears in 12 of 17 entries (e.g., Lifeward $27M on 2026-01-13; Scitara $9M on 2023-11-03; Meadowhawk Biolabs $9M on 2023-03-17). For sales and investor research, this means stage-informed comparisons will be limited, so deal context may need confirmation beyond the listing.
Are there notable outliers on the low end besides the $240M leader?
Yes: the smallest disclosed amount is Special Olympics Massachusetts at $10K on 2023-07-12, which is dramatically below the next-lowest disclosed figure shown (DNAiTECH at $460K on 2024-10-21). This makes the list’s disclosed values bimodal: very small-disclosure entries exist alongside mid-single-digit million rounds such as $4M (CardioFocus, 2022-04-12) and $5M (AssayQuant Technologies, 2023-07-10).
Which stage labels appear when the classification is not “Series Unknown,” and how many rows fall outside that label?
Outside “Series Unknown,” the stage labels include Series B (LiquidStack, $20M on 2024-09-19), Seed (Skyscape, $900K on 2022-02-15), Debt Financing (Main Street Bank, $25M on 2021-12-03), Post-IPO Equity (Rewalk Robotics, $33M on 2021-09-27), and Venture - Series Unknown (Wyebot $8M on 2022-05-05; CardioFocus $4M on 2022-04-12; OneShield Software $50M on 2022-01-27). That leaves 5 of 17 rows with an explicit stage label, compared with 12 of 17 labeled “Series Unknown.”
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.